UNAIDS deputy executive director Ms Jan Beagle said she was impressed by Zimbabwe's progress in the response to HIV. Commenting on the feasibility of increasing the initiation of ARVs to people living with HIV from a CD4 count of 350 to 500 under the proposed new World Health Organisation guidelines Ms Beagle said it was a process that might take time.
13 May 2013 | AllAfrica
On May 7 the National Institutes of Health, Centers for Disease Control and Prevention, and HIV Medicine Association of the Infectious Diseases Society of Americaannounced the release of revised Guidelines for the Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents, updating the previous version from 2009.
13 May 2013 | HIVandhepatitis.com
World Health Organization (WHO) announced this week at Treatment as Prevention conference in Vancouver, Canada, that it will raise treatment initiation guidelines for HIV-positive individuals from a CD4 count of less than 350 to a count of less than 500.
25 April 2013 | Wall Street Journal
The patient responded, “With all due respect to the guidelines, in the current era when there are increasingly well-tolerated medications, why would you use a regimen that included only 2 NRTIs without a third drug in any setting where there is a risk of HIV transmission?”
13 March 2013 | Clinical Care Options (requires registration)
The African nation of Malawi is getting an A+ for its aggressive approach to preventing HIV transmission from mothers to babies.
02 March 2013 | MedPage Today HIV/AIDS
We believe that a randomized, controlled trial should be undertaken immediately to determine when to initiate ART in Africa for maximal individual health benefit. It is feasible to conduct a large, simple trial to assess the risks and benefits of immediate ART versus deferral until a CD4+ count of 350 cells per cubic millimeter is reached.
23 February 2013 | New England Journal of Medicine
This article was prompted by contributions to the “when to start” debate that avoid both it’s complexity and the lack of evidence for benefits at higher CD4 counts. This issue has broad concern for HIV positive people, doctors and health workers, and public health policy.
23 February 2013 | HIV i-Base
Among the key changes are additional information about the most recently approved antiretroviral agents and a recommendation that newly infected people with HIV should be offered combination ART. The guidelines continue to recommend treatment for all people with HIV, both to reduce the risk of disease progressionand for the prevention of HIV transmission.
15 February 2013 | HIVandHepatitis.com
New recommendations on drug-resistance testing, genotypic tropism assays, starting treatment, acute infection, pregnancy and interactions.
15 February 2013 | AIDSinfo
This document is aimed at those working in HIV medicine, especially clinicians, and aims to provide information and guidance on managing issues related to sexual transmission of HIV. It applies generic ethical and professional principles but with a particular emphasis on providing a confidential environment in which sensitive matters can be discussed. The guidance sets out the roles and responsibilities of health care professionals when caring for individuals living with HIV.
13 February 2013 | HIV Justice Network